JP Morgan Chase’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.5B | Sell |
12,598,524
-1,099,967
| -8% | -$1.12B | 0.86% | 15 |
|
|
2026
Q1 | $12.1B | Buy |
13,698,491
+700,545
| +5% | +$710M | 0.78% | 18 |
|
|
2025
Q4 | $14B | Buy |
12,997,946
+2,729,791
| +27% | +$2.61B | 0.88% | 13 |
|
|
2025
Q3 | $7.83B | Sell |
10,268,155
-2,242,818
| -18% | -$1.67B | 0.47% | 29 |
|
|
2025
Q2 | $9.75B | Sell |
12,510,973
-968,945
| -7% | -$753M | 0.64% | 22 |
|
|
2025
Q1 | $11.1B | Sell |
13,479,918
-1,434,822
| -10% | -$1.19B | 0.81% | 17 |
|
|
2024
Q4 | $11.5B | Sell |
14,914,740
-3,351,381
| -18% | -$2.77B | 0.86% | 13 |
|
|
2024
Q3 | $16.2B | Sell |
18,266,121
-597,405
| -3% | -$537M | 1.23% | 7 |
|
|
2024
Q2 | $17.1B | Sell |
18,863,526
-387,439
| -2% | -$310M | 1.4% | 8 |
|
|
2024
Q1 | $15B | Sell |
19,250,965
-152,568
| -0.8% | -$109M | 1.27% | 7 |
|
|
2023
Q4 | $11.3B | Buy |
19,403,533
+3,600,341
| +23% | +$2.1B | 1.08% | 10 |
|
|
2023
Q3 | $8.49B | Buy |
15,803,192
+1,663,578
| +12% | +$857M | 0.94% | 11 |
|
|
2023
Q2 | $6.63B | Buy |
14,139,614
+3,228,109
| +30% | +$1.35B | 0.72% | 15 |
|
|
2023
Q1 | $3.75B | Sell |
10,911,505
-5,108,156
| -32% | -$1.72B | 0.46% | 41 |
|
|
2022
Q4 | $5.86B | Buy |
16,019,661
+1,261,226
| +9% | +$447M | 0.77% | 14 |
|
|
2022
Q3 | $4.77B | Sell |
14,758,435
-736,640
| -5% | -$233M | 0.69% | 18 |
|
|
2022
Q2 | $5.02B | Sell |
15,495,075
-801,157
| -5% | -$240M | 0.7% | 15 |
|
|
2022
Q1 | $4.67B | Sell |
16,296,232
-701,646
| -4% | -$181M | 0.56% | 24 |
|
|
2021
Q4 | $4.7B | Buy |
16,997,878
+1,312,944
| +8% | +$333M | 0.54% | 28 |
|
|
2021
Q3 | $3.62B | Sell |
15,684,934
-1,458,083
| -9% | -$360M | 0.45% | 36 |
|
|
2021
Q2 | $3.93B | Sell |
17,143,017
-189,805
| -1% | -$38.1M | 0.47% | 33 |
|
|
2021
Q1 | $3.24B | Sell |
17,332,822
-4,183,822
| -19% | -$818M | 0.43% | 39 |
|
|
2020
Q4 | $3.63B | Buy |
21,516,644
+2,674,219
| +14% | +$399M | 0.53% | 29 |
|
|
2020
Q3 | $2.76B | Buy |
18,842,425
+2,900,041
| +18% | +$449M | 0.46% | 37 |
|
|
2020
Q2 | $2.62B | Sell |
15,942,384
-1,413,825
| -8% | -$217M | 0.51% | 34 |
|
|
2020
Q1 | $2.41B | Sell |
17,356,209
-1,286,604
| -7% | -$177M | 0.57% | 30 |
|
|
2019
Q4 | $2.45B | Buy |
18,642,813
+3,091,191
| +20% | +$358M | 0.46% | 38 |
|
|
2019
Q3 | $1.74B | Sell |
15,551,622
-1,202,202
| -7% | -$134M | 0.35% | 56 |
|
|
2019
Q2 | $1.87B | Sell |
16,753,824
-1,235,003
| -7% | -$145M | 0.37% | 50 |
|
|
2019
Q1 | $2.33B | Buy |
17,988,827
+492,845
| +3% | +$59.9M | 0.48% | 37 |
|
|
2018
Q4 | $2.02B | Sell |
17,495,982
-762,101
| -4% | -$85.1M | 0.47% | 31 |
|
|
2018
Q3 | $1.96B | Sell |
18,258,083
-1,129,206
| -6% | -$113M | 0.38% | 44 |
|
|
2018
Q2 | $1.65B | Buy |
19,387,289
+3,438,532
| +22% | +$282M | 0.34% | 54 |
|
|
2018
Q1 | $1.23B | Sell |
15,948,757
-3,172,646
| -17% | -$255M | 0.26% | 73 |
|
|
2017
Q4 | $1.61B | Sell |
19,121,403
-1,489,076
| -7% | -$127M | 0.34% | 51 |
|
|
2017
Q3 | $1.75B | Sell |
20,610,479
-261,613
| -1% | -$21.5M | 0.39% | 42 |
|
|
2017
Q2 | $1.72B | Sell |
20,872,092
-15,272
| -0.1% | -$1.25M | 0.39% | 42 |
|
|
2017
Q1 | $1.76B | Sell |
20,887,364
-143,380
| -0.7% | -$11.5M | 0.4% | 41 |
|
|
2016
Q4 | $1.55B | Sell |
21,030,744
-216,932
| -1% | -$16.2M | 0.37% | 45 |
|
|
2016
Q3 | $1.71B | Sell |
21,247,676
-1,936,940
| -8% | -$155M | 0.42% | 37 |
|
|
2016
Q2 | $1.83B | Buy |
23,184,616
+671,416
| +3% | +$50.5M | 0.46% | 36 |
|
|
2016
Q1 | $1.62B | Sell |
22,513,200
-1,235,173
| -5% | -$93.5M | 0.42% | 40 |
|
|
2015
Q4 | $2B | Sell |
23,748,373
-468,119
| -2% | -$38.8M | 0.5% | 31 |
|
|
2015
Q3 | $2.03B | Buy |
24,216,492
+9,191,485
| +61% | +$776M | 0.54% | 29 |
|
|
2015
Q2 | $1.25B | Buy |
15,025,007
+7,743,373
| +106% | +$590M | 0.3% | 61 |
|
|
2015
Q1 | $529M | Buy |
7,281,634
+422,104
| +6% | +$30.1M | 0.12% | 190 |
|
|
2014
Q4 | $473M | Buy |
6,859,530
+13,290
| +0.2% | +$897K | 0.11% | 205 |
|
|
2014
Q3 | $444M | Sell |
6,846,240
-542,120
| -7% | -$34.3M | 0.11% | 220 |
|
|
2014
Q2 | $459M | Buy |
7,388,360
+1,089,684
| +17% | +$65M | 0.12% | 198 |
|
|
2014
Q1 | $371M | Buy |
6,298,676
+150,809
| +2% | +$8.42M | 0.1% | 218 |
|
|
2013
Q4 | $314M | Sell |
6,147,867
-1,355,913
| -18% | -$67.9M | 0.09% | 248 |
|
|
2013
Q3 | $378M | Sell |
7,503,780
-432,779
| -5% | -$22.7M | 0.11% | 216 |
|
|
2013
Q2 | $390M | Buy |
+7,936,559
| New | +$432M | 0.12% | 194 |
|
Other funds holding LLY
JP Morgan Chase's LLY Position: Q2 2026 in Review
JP Morgan Chase reduced its Eli Lilly (LLY) stake by 8% in Q2 2026, selling an estimated $1.12B and leaving 12,598,524 shares worth $15.5B. The position accounts for 0.86% of the portfolio, ranked #15.
JP Morgan Chase first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.1B in Q2 2024. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- JP Morgan Chase held 12,598,524 shares of Eli Lilly worth $15.5B as of Q2 2026.
- JP Morgan Chase sold 1,099,967 Eli Lilly shares in Q2 2026, an estimated $1.12B.
- Eli Lilly made up 0.86% of JP Morgan Chase's portfolio in Q2 2026, its #15 holding.
- JP Morgan Chase first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Eli Lilly position peaked at $17.1B in Q2 2024.
- 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.